img

Global Seasonal Influenza Vaccines Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Seasonal Influenza Vaccines Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Seasonal influenza vaccines are medical products used to prevent influenza virus infection and reduce the severity of flu symptoms during flu seasons.
Global Seasonal Influenza Vaccines Therapeutics market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
The market for seasonal influenza vaccines is driven by the demand for preventive healthcare measures and the need to reduce the burden of seasonal flu on healthcare systems. The market's growth is also influenced by the growing emphasis on vaccination and immunization programs globally.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Seasonal Influenza Vaccines Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


GSK
Novartis
CSL
MedImmune
Sanofi-Pasteur
Solvay
Hualan Biological Engineering
Sinovac Biotech
Changchun Institute of Biological Products Co., Ltd.
Shanghai Institute of Biological Products Co., Ltd.
Segment by Type
Paediatrics
Adolescence
Adults
Elderly

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Seasonal Influenza Vaccines Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Seasonal Influenza Vaccines Therapeutics introduction, etc. Seasonal Influenza Vaccines Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Seasonal Influenza Vaccines Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Seasonal Influenza Vaccines Therapeutics
1.1 Seasonal Influenza Vaccines Therapeutics Market Overview
1.1.1 Seasonal Influenza Vaccines Therapeutics Product Scope
1.1.2 Seasonal Influenza Vaccines Therapeutics Market Status and Outlook
1.2 Global Seasonal Influenza Vaccines Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region (2018-2029)
1.4 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Region (2018-2024)
1.5 Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.4 Latin America Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
2 Seasonal Influenza Vaccines Therapeutics Market by Type
2.1 Introduction
2.1.1 Paediatrics
2.1.2 Adolescence
2.1.3 Adults
2.1.4 Elderly
2.2 Global Seasonal Influenza Vaccines Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Type (2018-2024)
2.2.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
3 Seasonal Influenza Vaccines Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Seasonal Influenza Vaccines Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Application (2018-2024)
3.2.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
4 Seasonal Influenza Vaccines Therapeutics Competition Analysis by Players
4.1 Global Seasonal Influenza Vaccines Therapeutics Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2022)
4.3 Date of Key Players Enter into Seasonal Influenza Vaccines Therapeutics Market
4.4 Global Top Players Seasonal Influenza Vaccines Therapeutics Headquarters and Area Served
4.5 Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Seasonal Influenza Vaccines Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GSK
5.1.1 GSK Profile
5.1.2 GSK Main Business
5.1.3 GSK Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.1.4 GSK Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2024)
5.1.5 GSK Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.2.4 Novartis Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2024)
5.2.5 Novartis Recent Developments
5.3 CSL
5.3.1 CSL Profile
5.3.2 CSL Main Business
5.3.3 CSL Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.3.4 CSL Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2024)
5.3.5 MedImmune Recent Developments
5.4 MedImmune
5.4.1 MedImmune Profile
5.4.2 MedImmune Main Business
5.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.4.4 MedImmune Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2024)
5.4.5 MedImmune Recent Developments
5.5 Sanofi-Pasteur
5.5.1 Sanofi-Pasteur Profile
5.5.2 Sanofi-Pasteur Main Business
5.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.5.4 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2024)
5.5.5 Sanofi-Pasteur Recent Developments
5.6 Solvay
5.6.1 Solvay Profile
5.6.2 Solvay Main Business
5.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.6.4 Solvay Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2024)
5.6.5 Solvay Recent Developments
5.7 Hualan Biological Engineering
5.7.1 Hualan Biological Engineering Profile
5.7.2 Hualan Biological Engineering Main Business
5.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.7.4 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2024)
5.7.5 Hualan Biological Engineering Recent Developments
5.8 Sinovac Biotech
5.8.1 Sinovac Biotech Profile
5.8.2 Sinovac Biotech Main Business
5.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.8.4 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2024)
5.8.5 Sinovac Biotech Recent Developments
5.9 Changchun Institute of Biological Products Co., Ltd.
5.9.1 Changchun Institute of Biological Products Co., Ltd. Profile
5.9.2 Changchun Institute of Biological Products Co., Ltd. Main Business
5.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.9.4 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2024)
5.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Developments
5.10 Shanghai Institute of Biological Products Co., Ltd.
5.10.1 Shanghai Institute of Biological Products Co., Ltd. Profile
5.10.2 Shanghai Institute of Biological Products Co., Ltd. Main Business
5.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.10.4 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2024)
5.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Developments
6 North America
6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Seasonal Influenza Vaccines Therapeutics Market Dynamics
11.1 Seasonal Influenza Vaccines Therapeutics Industry Trends
11.2 Seasonal Influenza Vaccines Therapeutics Market Drivers
11.3 Seasonal Influenza Vaccines Therapeutics Market Challenges
11.4 Seasonal Influenza Vaccines Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Seasonal Influenza Vaccines Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Seasonal Influenza Vaccines Therapeutics Market Size Share by Region (2018-2024)
Table 4. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2018-2024)
Table 9. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2024-2029)
Table 11. North America Seasonal Influenza Vaccines Therapeutics Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Seasonal Influenza Vaccines Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Seasonal Influenza Vaccines Therapeutics Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Seasonal Influenza Vaccines Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2018-2024)
Table 24. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2024-2029)
Table 26. North America Seasonal Influenza Vaccines Therapeutics Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Seasonal Influenza Vaccines Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Seasonal Influenza Vaccines Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Seasonal Influenza Vaccines Therapeutics Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Seasonal Influenza Vaccines Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Seasonal Influenza Vaccines Therapeutics Market
Table 40. Global Seasonal Influenza Vaccines Therapeutics Key Players Headquarters and Area Served
Table 41. Seasonal Influenza Vaccines Therapeutics Product Solution and Service
Table 42. Global Seasonal Influenza Vaccines Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. GSK Basic Information List
Table 45. GSK Description and Business Overview
Table 46. GSK Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Seasonal Influenza Vaccines Therapeutics Business of GSK (2018-2024)
Table 48. GSK Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Seasonal Influenza Vaccines Therapeutics Business of Novartis (2018-2024)
Table 53. Novartis Recent Developments
Table 54. CSL Basic Information List
Table 55. CSL Description and Business Overview
Table 56. CSL Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Seasonal Influenza Vaccines Therapeutics Business of CSL (2018-2024)
Table 58. CSL Recent Developments
Table 59. MedImmune Basic Information List
Table 60. MedImmune Description and Business Overview
Table 61. MedImmune Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Seasonal Influenza Vaccines Therapeutics Business of MedImmune (2018-2024)
Table 63. MedImmune Recent Developments
Table 64. Sanofi-Pasteur Basic Information List
Table 65. Sanofi-Pasteur Description and Business Overview
Table 66. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Seasonal Influenza Vaccines Therapeutics Business of Sanofi-Pasteur (2018-2024)
Table 68. Sanofi-Pasteur Recent Developments
Table 69. Solvay Basic Information List
Table 70. Solvay Description and Business Overview
Table 71. Solvay Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Seasonal Influenza Vaccines Therapeutics Business of Solvay (2018-2024)
Table 73. Solvay Recent Developments
Table 74. Hualan Biological Engineering Basic Information List
Table 75. Hualan Biological Engineering Description and Business Overview
Table 76. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Seasonal Influenza Vaccines Therapeutics Business of Hualan Biological Engineering (2018-2024)
Table 78. Hualan Biological Engineering Recent Developments
Table 79. Sinovac Biotech Basic Information List
Table 80. Sinovac Biotech Description and Business Overview
Table 81. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Seasonal Influenza Vaccines Therapeutics Business of Sinovac Biotech (2018-2024)
Table 83. Sinovac Biotech Recent Developments
Table 84. Changchun Institute of Biological Products Co., Ltd. Basic Information List
Table 85. Changchun Institute of Biological Products Co., Ltd. Description and Business Overview
Table 86. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Seasonal Influenza Vaccines Therapeutics Business of Changchun Institute of Biological Products Co., Ltd. (2018-2024)
Table 88. Changchun Institute of Biological Products Co., Ltd. Recent Developments
Table 89. Shanghai Institute of Biological Products Co., Ltd. Basic Information List
Table 90. Shanghai Institute of Biological Products Co., Ltd. Description and Business Overview
Table 91. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Seasonal Influenza Vaccines Therapeutics Business of Shanghai Institute of Biological Products Co., Ltd. (2018-2024)
Table 93. Shanghai Institute of Biological Products Co., Ltd. Recent Developments
Table 94. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 95. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 96. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 97. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 98. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 100. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 101. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Region (2018-2024)
Table 102. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Region (2024-2029)
Table 103. Latin America Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 105. Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 106. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 108. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 109. Seasonal Influenza Vaccines Therapeutics Market Trends
Table 110. Seasonal Influenza Vaccines Therapeutics Market Drivers
Table 111. Seasonal Influenza Vaccines Therapeutics Market Challenges
Table 112. Seasonal Influenza Vaccines Therapeutics Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Seasonal Influenza Vaccines Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Seasonal Influenza Vaccines Therapeutics Market Share by Regions: 2022 VS 2029
Figure 4. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Paediatrics
Figure 11. Global Paediatrics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Adolescence
Figure 13. Global Adolescence Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Adults
Figure 15. Global Adults Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Elderly
Figure 17. Global Elderly Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Global Seasonal Influenza Vaccines Therapeutics Market Size Share by Type: 2022 & 2029
Figure 19. North America Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2018-2029)
Figure 20. Europe Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2018-2029)
Figure 21. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2018-2029)
Figure 22. Latin America Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2018-2029)
Figure 23. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2018-2029)
Figure 24. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Clinics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Global Seasonal Influenza Vaccines Therapeutics Market Size Share by Application: 2022 & 2029
Figure 28. North America Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2018-2029)
Figure 29. Europe Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2018-2029)
Figure 30. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2018-2029)
Figure 31. Latin America Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2018-2029)
Figure 32. Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Application (2018-2029)
Figure 33. Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Top 5 and Top 10 Players Seasonal Influenza Vaccines Therapeutics Market Share in 2022
Figure 35. North America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2018-2029)
Figure 36. United States Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 37. Canada Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 38. Germany Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 39. France Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 40. U.K. Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 41. Italy Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 42. Russia Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 43. Nordic Countries Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 44. Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Share by Region (2018-2029)
Figure 45. China Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 46. Japan Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 47. South Korea Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 48. Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 49. India Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 50. Australia Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 51. Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2018-2029)
Figure 52. Mexico Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 53. Brazil Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Share by Country (2018-2029)
Figure 55. Turkey Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 57. UAE Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries